PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma
Open Access
- 8 June 2017
- journal article
- case report
- Published by American Society of Hematology in Blood
- Vol. 129 (23), 3071-3073
- https://doi.org/10.1182/blood-2017-01-764209
Abstract
Key Points. Genetic analysis reveals frequent 9p24.1/PD-L1/PD-L2 copy-number alterations and increased expression of the PD-1 ligands in PCNSL and PTL.PD-1 bloKeywords
This publication has 23 references indexed in Scilit:
- Overcoming T cell exhaustion in infection and cancerTrends in Immunology, 2015
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's LymphomaNew England Journal of Medicine, 2015
- The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencingLeukemia, 2014
- Primary testicular lymphomaBlood, 2014
- High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphomaLeukemia, 2013
- Recent Advances in Treatment of Primary Central Nervous System LymphomaCurrent Treatment Options in Oncology, 2013
- Diagnosis and treatment of primary CNS lymphomaNature Reviews Neurology, 2013
- Cognitive functions in primary CNS lymphoma after single or combined modality regimensNeuro-Oncology, 2011
- Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue for Refractory and Recurrent Primary CNS and Intraocular Lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie CellulaireJournal of Clinical Oncology, 2008
- Results of Whole-Brain Radiation As Salvage of Methotrexate Failure for Immunocompetent Patients With Primary CNS LymphomaJournal of Clinical Oncology, 2005